Lexipafant
id:
lexipafant-237-4018152
title:
Lexipafant
text:
Lexipafant is a drug which acts as a potent and selective inhibitor of the phospholipid mediator platelet-activating factor (PAF). It was developed in the 1990s by British Biotech with several potential applications, including HIV-associated neurocognitive disorder and acute pancreatitis. Initial results were encouraging and it progressed as far as Phase III clinical trials, but final analysis of trial results showed that it failed to improve survival rates in pancreatitis despite some symptomat
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Lexipafant
date created:
date modified:
2023-09-02T17:13:01Z
main entity:
{"identifier":"Q27279470","url":"https://www.wikidata.org/entity/Q27279470"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1c/Lexipafant_structure.png","width":1162,"height":914}
fields total:
13
integrity:
15